Brief: IDT Australia Secures Manufacturing Contract With Nacuity Pharmaceuticals For RP Treatment
09/04/2025 02:28
April 9 (Reuters) - IDT Australia Ltd IDT.AX: SECURES MANUFACTURING CONTRACT WITH NACUITY PHARMACEUTICALS FOR RP TREATMENT FIVE-YEAR CONTRACT WITH INITIAL A$3.2M WORK EXPECTED TO COMPLETE BY FY2026 Further company coverage: IDT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IDT Australia
See all newsBrief: IDT Australia Sees Unaudited Fy26 Revenue From Three Verticals To Rise To A$16.8 Million
IDT Australia soars on upgraded annual earnings forecasts
IDT Australia climbs on positive FY26 outlook
Brief: Idt Australia Forecasts FY26 EBITDA Loss Of A$1.5m-A$2m
IDT Australia eyes strongest session in over four years as EBITDA loss narrows